B细胞性血液肿瘤的多药耐药逆转
Multi-drug resistance in B cell of hematologicalm alignancies and its reversal
摘要
B淋巴细胞的增殖与分化异常与急慢性淋巴细胞性白血病及淋巴瘤等血液系统恶性肿瘤密切相关 ,目前该类疾病主要治疗措施之一是化疗 ,但B细胞对化疗药物产生多药耐药 (MDR)已成为限制疗效的关键因素。近年研究证实 ,利用耐药逆转剂、基因治疗及免疫治疗可不同程度逆转MDR。
出处
《国外医学（肿瘤学分册）》
2004年第8期635-637,共3页
Foreign Medical Sciences (Cancer Section)
参考文献14
-
1Lopes EC, Garcia M, Benavides F, et al. Multidrug resistance modulators PSC 833 and CsA show differential capacity to induce apoptosis in lymphoid leukemia cell lines independently of their MDR phenotype. Leuk Res, 2003, 27(5):413-423.
-
2Ganeshaguru K, Wickremasinghe RG, Jones DT, et al. Actions of the s elective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitro. Haematologica, 2002,87 ( 2 ): 167-176.
-
3Inoue H, Takemura H, Kawai Y, et al. Dexamethasone-resistant human Pre-B leukemia 697 cell line evolving elevation of intracellular glutathione level: an additional resistance mechanism. Jpn J Cancer Res, 2002, 93(5): 582-590.
-
4Mistry P, Stewart AJ, Dangerfield W, et al. In vitro and in vivo characterization of XRl1576, a novel, orally active, dual inhibitor of topoisomerase Ⅰ and Ⅱ .Anticancer Drugs,2002,13(l):15-28.
-
5Stuart DD, Kao GY, Allen TM. A novel, long-circulating, and functional liposomal formulation of antisense oligodeoxynucleotides targeted against mdrl. Cancer Gene Ther, 2000,7 (3): 466-475.
-
6Wu H, Hait WN, Yang JM. Small interfering RNA-induced suppression of MDB1 (P-glycoprotein) restores sensitivity to multidrug- resistant cancer cells. Cancer Res,2003,63(7): 1515-1519.
-
7Cotter FE. Antisense therapy of hematologic malignancies. Semin Hematol, 1999,36(4 Suppl 6) :9-14.
-
8Johnson TA, Press OW. Therapy of B-cell lymphomas with monoclonal antibo- dies and radioimmunoconjugates: the Seattle experience. Ann Hematol,2000, 79(4): 175-182.
-
9Alas S, Emmanouilides C, Bonavida B. Inhibition of interleukin 10 by Rituximab results in down-regulation of Bcl-2 and sensitization Of B-cell non-Hodgkins's lymphoma to apoptosis. Clin Cancer Res, 2001,7 ( 3 ):709-723.
-
10Alas S, Ng CP, Bonavida B. Rituximab modifies the Cisplatin-mitochondrial signaling pathway, resulting in apoptosis in Cisplatin-resistant non- Hodgkin's lymphoma. Clin Cancer Res, 2002,8 (3): 836-845.
-
1陈良安,刘又宁.反义核酸对人肺腺癌细胞多药耐药逆转的实验研究[J].中华医学杂志,2000,80(3):219-221. 被引量：4
-
2徐丽丽,王扬,杨建民.嵌合抗原受体T细胞在B细胞性血液肿瘤中的研究进展[J].白血病．淋巴瘤,2014,23(12):757-760. 被引量：2
-
3李启英,吴立翔.非何杰金淋巴瘤合并白血病20例[J].现代医药卫生,2003,19(9):1127-1127.
-
4樊改荣.VCAP方案治疗急性淋巴细胞性白血病32例临床分析[J].中国药物与临床,2006,6(12):931-932. 被引量：1
-
5夏瑞南,盛尔荃.急性原淋巴细胞性白血病侵犯眼眶三例[J].中华眼科杂志,1992,28(4):251-252.
-
6刘玉忠,郭淑贞,等.大肠癌多药耐药逆转的临床研究[J].医师进修杂志,2002,25(11):32-33. 被引量：1
-
7王开雷,李乐平,靖昌庆.大肠癌多药耐药逆转的研究进展[J].中国现代普通外科进展,2010,13(4):306-310. 被引量：7
-
8张伟,刘叙仪,王洁,蒋微,张毅,刘元林,王曾礼.人参皂甙Rg3对耐顺铂人肺腺癌细胞系A_(549)^(DDP)逆转作用及其机理的研究[J].中国呼吸与危重监护杂志,2002,1(2):100-103. 被引量：30
-
9夏瑞祥,曾庆曙,蔡学杰.白血病多药耐药逆转的研究进展[J].安徽医药,2001,5(1):3-4. 被引量：1
-
10王承正,袁鹏,杨晗昭,孙恒.miR-126对人乳腺癌细胞增殖和侵袭的影响[J].医药论坛杂志,2016,37(8):72-74. 被引量：6
